Not Yet Recruiting
SMARCA4/2 Inhibitor for POU2F3-Positive SCLC
NCT07551635
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States